Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD

Lofdahl C-G., Postma D. S., Pride N. B., Boe J., Thoren A.

Source: Eur Respir J 2007; 29: 1115-1119
Journal Issue: June
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lofdahl C-G., Postma D. S., Pride N. B., Boe J., Thoren A.. Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD. Eur Respir J 2007; 29: 1115-1119

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD
Source: Eur Respir J 2010; 35: 1003-1021
Year: 2010



Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD
Source: Eur Respir J 2005; 25: 634-639
Year: 2005



Airways obstruction is associated with increased cardiac injury and systemic inflammation in patients with stable COPD
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006


Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

Possible mechanisms of ventricular arrhythmias in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005

Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007


Use of metoprolol succinate in patients with cardiovascular diseases associated with asthma or chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 502s
Year: 2006

Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013


Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001

Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006

The effects of elevated troponin I on long-term mortality after chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009


A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 217-224
Year: 2002



Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009

Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?
Source: Eur Respir J 2003; 21: 260-266
Year: 2003



Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012


Bronchodilatory effects of formoterol in patients with chronic obstructive pulmonary disease (COPD) are not influenced by concomitant corticosteroid use
Source: Eur Respir J 2001; 18: Suppl. 33, 514s
Year: 2001

Acute effects of sildenafil in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008

Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012

The effect of short-acting beta-two-agonist on pulmonary rehabilitation in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease
Year: 2009

Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2011 - COPD management
Year: 2011